Filing Flows › Envoy Medical (COCH) › Q3 2025
Envoy Medical (COCH) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 10, 2025
Envoy Medical (COCH) reported revenue of $42K for the third quarter 2025 (Q3 2025), -25% from a year earlier and -46% from the quarter before.
Envoy Medical, Q3 2025: revenue $42K (-25% year over year), net loss $6.5M, operating cash flow −$4.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $42K | -46% | -25% |
| Operating profit | −$5.7M | — | — |
| Net earnings | −$6.5M | — | — |
| Operating cash flow | −$4.3M | — | — |
What changed
Revenue was $42K in Q3 2025, down 25% year over year and down 46% from the previous quarter.
Operating costs exceeded revenue by $5.7M, an operating margin of -13590.5%. Total costs grew 14% against a revenue fall of 25%. The fastest-growing cost line was General & admin (+44%). The quarter ended with a net loss of $6.5M, wider than the previous quarter's $5.7M loss.
Operating cash flow was −$4.3M. Non-cash charges added back $76K of depreciation and $172K of share-based compensation. Working capital and other items added $1.9M.
Questions
What was Envoy Medical's revenue in the third quarter 2025?
Envoy Medical (COCH) reported revenue of $42K for the third quarter 2025 (Q3 2025), -25% from a year earlier and -46% from the quarter before.
Source: Envoy Medical 10-Q on SEC EDGAR.